Tan Gabriel, Rintala Diana H, Jensen Mark P, Richards J Scott, Holmes Sally Ann, Parachuri Rama, Lashgari-Saegh Shamsi, Price Larry R
Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.
J Spinal Cord Med. 2011;34(3):285-96. doi: 10.1179/2045772311Y.0000000008.
Chronic pain is a significant problem for many individuals following spinal cord injury (SCI). Unfortunately, SCI-related neuropathic pain has proven to be largely refractory to analgesic medications and other available treatments. Cranial electrotherapy stimulation (CES) has been effective in managing some types of pain. It involves the application of a small amount of current through the head via ear clip electrodes.
Explore the effectiveness of CES for neuropathic pain in persons with SCI and chronic pain.
Multi-site, double-blind, sham-controlled study.
Adults with SCI and chronic neuropathic pain at or below the level of injury were randomized to receive active or sham CES.
Application of active CES or sham CES 1 hour daily for 21 days. Six-month open-label phase to assess 'as-needed' CES use.
Change in pre- to post-session pain ratings as well as change in pain intensity, pain interference, pain quality, pain beliefs and coping strategies, general physical and mental health status, depressive symptomatology, perceived stress, and anxiety pre- to post-treatment.
The active group reported a significantly greater average decrease in pain during daily treatments than the sham group (Kruskal-Wallis chi-square = 4.70, P < 0.05). During the 21-day trial, there was a significant group × time interaction for only one outcome variable; the active group showed larger pre- to post-treatment decreases in pain interference than the sham group did (F = 8.50, P < 0.01, d = 0.59).
On average, CES appears to have provided a small but statistically significant improvement in pain intensity and pain interference with few troublesome side effects. Individual results varied from no pain relief to a great deal of relief.
慢性疼痛是许多脊髓损伤(SCI)患者面临的重大问题。不幸的是,事实证明,与SCI相关的神经性疼痛在很大程度上对止痛药物和其他现有治疗方法具有抗性。颅电刺激(CES)已被证明在治疗某些类型的疼痛方面有效。它涉及通过耳夹电极将少量电流通过头部施加。
探讨CES对SCI和慢性疼痛患者神经性疼痛的有效性。
多中心、双盲、假对照研究。
损伤水平及以下患有SCI和慢性神经性疼痛的成年人被随机分配接受活性或假CES治疗。
每天应用活性CES或假CES 1小时,共21天。进行为期6个月的开放标签阶段,以评估“按需”使用CES的情况。
治疗前至治疗后疼痛评分的变化,以及疼痛强度、疼痛干扰、疼痛性质、疼痛信念和应对策略、总体身心健康状况、抑郁症状、感知压力和焦虑在治疗前至治疗后的变化。
活性组在每日治疗期间报告的疼痛平均下降幅度明显大于假治疗组(Kruskal-Wallis卡方检验=4.70,P<0.05)。在为期21天的试验中,仅一个观察变量存在显著的组×时间交互作用;活性组在治疗前至治疗后疼痛干扰的下降幅度大于假治疗组(F=8.50,P<0.01,d=0.59)。
平均而言,CES似乎在疼痛强度和疼痛干扰方面带来了微小但具有统计学意义的改善,且副作用较少。个体结果差异较大,从无疼痛缓解到大量缓解不等。